Drug Industry Critic Tapped For FDA Seat

Law360, New York (January 9, 2009, 12:00 AM EST) -- A long-standing opponent of the pharmaceutical industry has reportedly been appointed to a four-year term on a committee that advises the U.S. Food and Drug Administration on drug safety issues, a move that could signal a shift toward tougher regulation of Big Pharma.

Dr. Sidney Wolfe, head of the health research group at nonprofit advocacy firm Public Citizen, was named to the FDA's Drug Safety and Risk Management Committee full-time in August at the urging of consumer groups that were owed a seat on the panel,...
To view the full article, register now.